Health Care Sector Update for 01/23/2017: IMNP
Top Health-care stocks:
Health-care shares were mixed in pre-market trade Monday.
In health-care stocks news, Immune Pharmaceuticals ( IMNP ) has signed an exclusive sub-license agreement with French manufacturer SATT Sud-Est, to develop mono- and bispecific antibodies targeting components of the tumor microenvironment and angiogenic factors.
Shares in the company were 3.7% higher at $0.23 in pre-market trade. The stock has traded between $0.16 and $0.64 over the past 52 weeks.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.